Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Surgical treatment of the neck in patients with salivary gland carcinoma

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma"

    Research output: Contribution to journalLetterResearchpeer-review

  2. Prognostic scoring models in parotid gland carcinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Nasopharyngeal malignancies in Denmark diagnosed from 1980 to 2014

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of human papillomavirus in sinonasal cancer-a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  3. Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma"

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations

BACKGROUND: Elective neck dissection (END) in patients with salivary gland carcinoma is controversial and there are no universally accepted guidelines.

METHODS: Patients were identified from the Danish Head and Neck Cancer Group. Between 2006 and 2015, 259 patients with primary salivary gland carcinoma were treated with END. Variables potentially associated with regional metastases were analyzed using logistic regression. Neck recurrence-free survival was calculated using the Kaplan-Meier method.

RESULTS: Occult metastases were found in 36 of the patients treated with END (14%) and were particularly frequent among patients with T3/T4 tumors and high-grade histology tumors. In multivariate analyses, high-grade histology and vascular invasion were associated with occult metastases.

CONCLUSION: We recommend END of levels II and III for patients with high-grade or unknown histological grade tumors, and for T3/T4 tumors. Levels I, II, and III should be included in END in patients with submandibular, sublingual, or minor salivary gland carcinomas.

Original languageEnglish
JournalHead and Neck
Volume43
Issue number6
Pages (from-to)1898-1911
Number of pages14
ISSN1043-3074
DOIs
Publication statusPublished - Jun 2021

    Research areas

  • cervical lymph nodes, neck dissection, regional metastases, salivary gland carcinoma, surgery

ID: 65606776